Nvidia’s investment isn’t just working capital for Recursion Pharmaceuticals’ technology-driven drug discovery research. Recursion says it will get more computing power as well as the ...

Recursion, which utilizes artificial intelligence to help speed up the drug discovery process, said Nvidia's investment would accelerate its work in AI-powered drug development.

SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023-- Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced a $50 million ...

SALT LAKE CITY, Nov. 20, 2024-- The business combination of two AI-powered drug discovery and development companies, Recursion and Exscientia has been completed, with Exscientia becoming a wholly ...

The Gateway in Salt Lake City took a major leap this week in its evolution into something more than a retail center, with the addition of Recursion Pharmaceuticals as a core tenant.

Altitude Lab, a biotech accelerator formed by Recursion, on Wednesday announced the launch of a pre-seed venture fund to support early-stage startups affected by the changes in federal funding policy.